ADMA Biologics Inc vs InMode Ltd — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while InMode Ltd trades at $15.16 (market cap $872.08M). The key difference: ADMA Biologics Inc is far larger — about 2.5× InMode Ltd's market cap, and InMode Ltd is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | INMD | |
|---|---|---|
Market Cap | $2.22B | $872.08M |
Sector | Health | Technology |
52-Week High | $20.38 | $16.62 |
52-Week Low | $7.60 | $12.76 |
Enterprise Value | $2.29B | $375.42M |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →